NM_000424.4(KRT5):c.110G>A (p.Arg37Gln) AND multiple conditions
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Jan 8, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002480117.1
Allele description [Variation Report for NM_000424.4(KRT5):c.110G>A (p.Arg37Gln)]
NM_000424.4(KRT5):c.110G>A (p.Arg37Gln)
Condition(s)
- Name:
- Epidermolysis bullosa simplex with migratory circinate erythema
- Synonyms:
- EBS-migr; Epidermolysis bullosa simplex 2E, with migratory circinate erythema
- Identifiers:
- MONDO: MONDO:0012258; MedGen: C1836284; Orphanet: 158681; OMIM: 609352
- Name:
- Epidermolysis bullosa simplex with mottled pigmentation (EBS2F)
- Synonyms:
- SPECKLED HYPERPIGMENTATION WITH PUNCTATE PALMOPLANTAR KERATOSES AND CHILDHOOD BLISTERING; EBS with mottled pigmentation; Speckled hyperpigmentation, palmo-plantar punctate keratoses and childhood blistering; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0007556; MedGen: C0432316; Orphanet: 79397; OMIM: 131960
- Name:
- Epidermolysis bullosa simplex 1A, generalized severe (EBS1A)
- Synonyms:
- Epidermolysis bullosa herpetiformis, Dowling-Meara; Epidermolysis bullosa simplex Dowling-Meara type
- Identifiers:
- MONDO: MONDO:0007550; MedGen: C0079295; Orphanet: 79396; OMIM: 131760
- Name:
- Dowling-Degos disease 1
- Identifiers:
- MONDO: MONDO:0024534; MedGen: C4552092; Orphanet: 79145; OMIM: 179850
- Name:
- Epidermolysis bullosa simplex 2A, generalized severe
- Synonyms:
- Epidermolysis bullosa simplex 2, generalized severe; Epidermolysis bullosa simplex 2, Dowling-Meara type; Epidermolysis bullosa simplex 2, severe
- Identifiers:
- MONDO: MONDO:0030489; MedGen: CN301077; OMIM: 619555
- Name:
- Epidermolysis bullosa simplex 2B, generalized intermediate (EBS2B)
- Synonyms:
- Epidermolysis bullosa simplex 2B, Koebner type
- Identifiers:
- MONDO: MONDO:0030525; MedGen: C5562009; OMIM: 619588
Assertion and evidence details
Last Updated: Sep 29, 2024